Myriad Genetics Informs Crescendo Bio of Interest in Acquisition | GenomeWeb

NEW YORK (GenomeWeb News) – Myriad Genetics has informed Crescedo Bioscience of its “preliminary, non-binding interest” in acquiring the company, Myriad said in a regulatory document today.

The Salt Lake City firm informed Crescendo of its interest on Tuesday after Crescendo sent notice to Myriad on Nov. 14 that it had achieved a minimum revenue milestone, which gave Myriad the option to acquire Crescendo.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Ivanka Trump and Secretary of Education Betsy DeVos call on girls to pursue STEM careers, the Associated Press reports.

Some science companies will be taking part in next month's March for Science, Fortune reports.

In Genome Research this week: longitudinal study of Burkholderia cenocepacia isolates from cystic fibrosis patients, long-read assembly approach, and more.

Shale oil companies are turning to DNA sequencing to find spots to drill, Reuters reports.